Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
Clinical trial NCT05938387 · COMPLETED
Trial details
- NCT number
- NCT05938387
- Sponsor
- CureVac
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2026-02-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.